论文部分内容阅读
近几年来,肝素或硫酸镁对肺源性心脏病(下简称肺心病)的治疗作用日益受到重视,笔者用肝素—硫酸镁联合治疗肺心病难治性心衰15例,获得显著疗效,现报告如下: 1.临床资料本文的诊断依据系按1977年全国第二次肺心病专业会议修订的肺心病诊断标准。其中男12例,女3例,年龄50～70岁。均有轻重不同的肺淤血或(和)肺水肿征(呼吸困难、咳痰、紫绀、肺部湿性罗音),并有体循环淤血征(少尿、足肿、肝肿大、颈静脉怒张、肝颈回流征阳性),顽固性水肿10例。并发洋地黄中毒室早2例。Ⅱ度Ⅰ型房室传导阻滞2例。顽固性低血钾2例。15例中有10例测血清镁,低于1.5mEq/L者6例。本组病人经休息、吸氧、限盐、应用洋地黄、利尿剂以及激素:抗感染和改善呼吸等常规抗心衰
In recent years, heparin or magnesium sulfate on the treatment of pulmonary heart disease (hereinafter referred to as pulmonary heart disease) is increasingly valued, the author with heparin - magnesium sulfate combined treatment of refractory heart failure pulmonary heart disease in 15 cases, a significant effect, and now The report is as follows: 1. Clinical data The diagnostic basis of this article is based on the diagnostic criteria for pulmonary heart disease revised by the Second National Conference of Pulmonary Heart Disease in 1977. Including 12 males and 3 females, aged 50 to 70 years. There are different levels of pulmonary congestion or pulmonary edema (dyspnea, sputum, cyanosis, pulmonary rales), and systemic congestion signs (oliguria, foot swelling, hepatomegaly, jugular vein engorgement , Liver reflux sign positive), refractory edema in 10 cases. Digitalis poisoning room as early as 2 cases. Ⅱ degree Ⅰ type atrioventricular block in 2 cases. 2 cases of intractable hypokalemia. 10 cases of 15 cases of serum magnesium, less than 1.5mEq / L in 6 cases. The patient after a break, oxygen, salt, application of digitalis, diuretics and hormones: anti-infective and improve breathing and other conventional anti-heart failure